Join to view full profile
510 E 70th St# 582New York, NY 10021
Phone+1 212-746-9868
Fax+1 212-746-8572
Dr. Houvras is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2004 - 2008
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2003
Icahn School of Medicine at Mount SinaiClass of 2001
Certifications & Licensure
NY State Medical License 2011 - 2028
MA State Medical License 2005 - 2011
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Publications & Presentations
PubMed
- Author Correction: Common and rare variant associations with clonal haematopoiesis phenotypes.Michael D Kessler, Amy Damask, Sean O'Keeffe, Nilanjana Banerjee, Dadong Li
Nature. 2025-01-01 - 81 citationsLinvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma.Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman
Journal of Clinical Oncology. 2024-08-01 - Author Correction: Common and rare variant associations with clonal haematopoiesis phenotypes.Michael D Kessler, Amy Damask, Sean O'Keeffe, Nilanjana Banerjee, Dadong Li
Nature. 2023-03-01
Journal Articles
- Oxidative Phosphorylation Promotes Primary Melanoma InvasionFarbod Darvishian, Yariv Houvras, The American Journal of Pathology
Press Mentions
Models of TransparencyMarch 31st, 2013
Grant Support
- Hematopoietic Stem Cell Development In ZebrafishNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Hematopoietic Stem Cell Development In ZebrafishNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
- Hematopoietic Stem Cell Development In ZebrafishNational Institute Of Diabetes And Digestive And Kidney Diseases2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
